PAR6 A COMPARISON OF HEALTH CARE COSTS IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA) WHO RECEIVED ETANERCEPT (ETA), ETA PLUS METHOTREXATE (MTX), INFLIXIMAB (INF), OR INF PLUS MTX
Abstract
Authors
O Dabbous M Rahman BL Meissner H Thompson B Tang